Sec Form 4 Filing - MORONEY JOHN J @ AMERICAN BIO MEDICA CORP - 2017-05-08

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person MORONEY JOHN J 2. Issuer Name and Ticker or Trading Symbol AMERICAN BIO MEDICA CORP [ ABMC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 118 PEGASUS DRIVE 3. Date of Earliest Transaction (MM/DD/YY) 05/08/2017 (Street) JUPITER, FL33477 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price COMMON STOCK 05/08/2017( 1 ) J( 2 ) 245,545 A $ 0 1,887,838 I By: Landmark Pegasus, Inc.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other MORONEY JOHN J 118 PEGASUS DRIVE JUPITER, FL33477 X Signatures JOHN J MORONEY 05/17/2017 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The transfer agent was instructed to issue shares on May 8th, 2017. Transfer agent confirmed transaction was completed on May 15th, 2017. ( 2 )Landmark Pegasus, Inc. acquired the securities being reported as payment (from the issuer) of a fee pursuant to a Financial Advisor Agreement with the Issuer. The total amount of securities issued was 454,545 of which only 254,545 were issued to Landmark Pegasus, Inc. The remaining 200,000 common stock were issued to another principal of Landmark Pegasus, Inc who does not control the Landmark Pegasus, Inc shares and who is not a 10% owner or affiliate of the Company.

Remarks: In addition to the common shares indicated, the reporting person shares beneficial ownership of a presently exercisable warrant to acquire 200,000 shares of common stock held by F&M Investment Partnership. In total, the reporting person is the beneficial owner of 4,096,171 shares of common stock of the Issuer.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.